Share This Author
Cardiac Tumors: Clinical Perspective and Therapeutic Considerations.
- Dylan Y Ren, Nathan D. Fuller, Sara A B Gilbert, Yingmei Zhang
- Current drug targets
- 30 November 2017
This mini-review tries to summarize recent understanding of the pathogenesis and therapeutics of cardiac tumors. Expand
Cardiovascular Benefit of SGLT2 Inhibitors in the Therapeutics of Diabetes Mellitus: A Close Look beyond the Horizon.
This mini-review will briefly discuss the various cardiovascular benefits of SGLT2 inhibitors, and the underlying mechanisms involved. Expand
A Nutraceutical Formulation Improves Cardiometabolic Parameters in Obese/Overweight Subjects
GlycaCare™ -Plus is a novel proprietary dietary formulation comprising Pterocarpus and GlycaCare -Plus that is an independent risk factor for diabetes and cardiovascular disease. Expand